Bonaduce D, Postiglione M, Ferrara N, Petretta M, De Caprio L, Rengo F
Minerva Med. 1981 Feb 28;72(7):333-7.
The effects of oral administration of guaiacolic ester of acetyl salicilic acid in 24 patients with chronic obstructive lung disease have been evaluated. 1.5 g of this drug were given daily into 3 administrations improving both objective and subjective symptomatology in 19 of the 24 patients after 1 or 3 weeks of treatment. Moreover, a statistically significant improvement of FEV 1" (p less than 0.001), Raw (p less than 0.005) and FEV 1"/VC (p less than 0.01) was observed. The remaining 5 patients discontinued the treatment failing the improvement of the subjective symptomatology.
已评估口服乙酰水杨酸愈创木酯对24例慢性阻塞性肺疾病患者的疗效。每日给予该药物1.5克,分3次服用,治疗1周或3周后,24例患者中有19例的客观和主观症状均得到改善。此外,观察到第1秒用力呼气量(FEV₁)(p<0.001)、气道阻力(Raw)(p<0.005)和FEV₁/肺活量(VC)(p<0.01)有统计学意义的改善。其余5例患者因主观症状未改善而停止治疗。